Cadrenal Therapeutics

(NASDAQ) CVKD

Current Price$4.15

Market Cap$11.56M

Since IPO (2023)-93%

5 YearN/A

1 Year-73%

1 Month-22%

Cadrenal Therapeutics Financials at a Glance

Market Cap

$11.56M

Revenue (TTM)

$0.00

Net Income (TTM)

-$11.89M

EPS (TTM)

-$5.63

P/E Ratio

-0.72

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Price

$4.15

Volume

30,456.571

Open

$4.11

Price

$4.15

Volume

30,456.571

Open

$4.11

Previous Close

$4.03

Daily Range

$4.03 - $4.26

52-Week Range

$3.90 - $14.69

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Price

$4.15

Volume

30,456.571

Open

$4.11

Previous Close

$4.03

Daily Range

$4.03 - $4.26

52-Week Range

$3.90 - $14.69

Estimated Earnings Date

Aug 6, 2026

CVKD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cadrenal Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Quang X. Pham

Website

www.cadrenal.com

Headquarters

Ponte Vedra, FL 32082, US

CVKD Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-301%

Return on Capital

-7%

Return on Assets

-4%

Earnings Yield

-1.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.56M

Shares Outstanding

2.87M

Volume

30.46K

Avg. Volume

59.11K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$13.46M

EBITDA

-$13.23M

Operating Cash Flow

-$12.60M

Capital Expenditure

-$5.10K

Free Cash Flow

-$12.60M

Cash & ST Invst.

$4.01M

Total Debt

$0.00

Cadrenal Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$555.00

+89.9%

Gross Margin

0.00%

N/A

Market Cap

$11.56M

N/A

Market Cap/Employee

$2.89M

N/A

Employees

N/A

Net Income

-$2.50M

+35.1%

EBITDA

-$2.50M

+35.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$2.31M

-68.5%

Total Debt

$0.00

N/A

Accounts Receivable

$5.47K

-77.8%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-4.15%

N/A

Return on Invested Capital

-6.70%

N/A

Free Cash Flow

-$3.00M

+35.5%

Operating Cash Flow

-$3.00M

+35.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TAOXTAO Synergies Inc.

TAOXTAO Synergies Inc.$3.82+4.66%

SONNSonnet BioTherapeutics Holdings, Inc.

SONNSonnet BioTherapeutics Holdings, Inc.$1.26-59.35%

XCURExicure, Inc.

XCURExicure, Inc.$2.82+2.17%

NRSNNeuroSense Therapeutics Ltd.

NRSNNeuroSense Therapeutics Ltd.$0.74+1.05%

CLGNCollPlant Biotechnologies Ltd.

CLGNCollPlant Biotechnologies Ltd.$0.33-7.99%

ITRMIterum Therapeutics plc

ITRMIterum Therapeutics plc$0.03-10.98%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.67-1.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

LYGLloyds Banking Group Plc

LYGLloyds Banking Group Plc$5.42+0.05%

NVDANvidia

NVDANvidia$205.03+0.02%

CPNGCoupang

CPNGCoupang$17.32+0.15%

NOKNokia

NOKNokia$14.09+0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.01+0.10%

ORCLOracle

ORCLOracle$184.19-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.83-0.10%

Questions About CVKD

What is the current price of Cadrenal Therapeutics?

Cadrenal Therapeutics is trading at $4.03 per share.

What is the 52-week range for Cadrenal Therapeutics?

Over the past 52 weeks, Cadrenal Therapeutics has traded between $3.90 and $14.69.

How much debt does Cadrenal Therapeutics have?

As of the most recent reporting period, Cadrenal Therapeutics reported total debt of $0.00.

How much cash does Cadrenal Therapeutics have on hand?

Cadrenal Therapeutics reported $2.31M in cash and cash equivalents in its most recent financial results.

What is Cadrenal Therapeutics’s dividend yield?

Cadrenal Therapeutics does not currently have a dividend yield.

Cadrenal Therapeutics

Cadrenal Therapeutics Financials at a Glance

CVKD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cadrenal Therapeutics

CVKD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cadrenal Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CVKD

What is the current price of Cadrenal Therapeutics?

What is the 52-week range for Cadrenal Therapeutics?

How much debt does Cadrenal Therapeutics have?

How much cash does Cadrenal Therapeutics have on hand?

What is Cadrenal Therapeutics’s dividend yield?

Premium Investing Services